| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042186A1 Novel polypeptide ligands for toll-like receptor 2 (TLR2) |
| 04/01/2009 | EP2041175A1 Targeted immune conjugates |
| 04/01/2009 | EP2041171A2 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1456239B1 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1292613B9 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 04/01/2009 | EP1119623B1 Mage-a3 peptides presented by hla class ii molecules |
| 04/01/2009 | CN101397569A Method for improving tobacco virus resistance |
| 04/01/2009 | CN101397563A T2r taste receptors and genes encoding same |
| 04/01/2009 | CN101397562A Construction method for major histocompatibility complex/peptide tetramer for chicken and products thereof |
| 04/01/2009 | CN101397343A VEGF receptor fusion protein and its use in preparation of medicament for treating eye disease |
| 04/01/2009 | CN100473724C Novel VIP3 toxins and methods of use |
| 04/01/2009 | CN100473663C Heterologous expression of neisserial proteins |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/26/2009 | WO2009038475A1 Systems for expression of heterologous proteins in m. capsulatus |
| 03/26/2009 | WO2004080387A3 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090081753 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081707 Human trk receptors and neurotrophic factor inhibitors |
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081199 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | CA2699944A1 Targeted interferon demonstrates potent apoptotic and anti-tumor activities |
| 03/26/2009 | CA2699394A1 Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
| 03/25/2009 | EP2037737A2 Proteins, nucleic acids encoding the same and associated methods of use |
| 03/25/2009 | CN101392027A Fusion protein for treating alzheimer's disease and preparation method thereof |
| 03/25/2009 | CN100471955C A fusion gene, it expressed protein and producing process thereof |
| 03/25/2009 | CN100471950C Polypeptides having alpha- h-alpha-amino acid amide racemase activity and nucleic acids encoding the same |
| 03/25/2009 | CN100471873C A series of polypeptide capable of blocking IL-6 |
| 03/25/2009 | CN100471872C Optimizing fusion protein containing VEGF recerver segment and medical application thereof |
| 03/25/2009 | CN100471868C Compositions and methods for WT1 specific immunotherapy |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507555 polypeptides linked to chromogens capable of fluorescence resonance energy transfer, used for the quantitative analysis of molecules that relay signals received at receptors on a cell surface to target molecules in the cytosol and/or nucleus |
| 03/24/2009 | US7507544 Comprises nucleotide sequences coding mammalian taste-cell-specific G protein-coupled receptors for use in identifying agents which modify chemosensory taste transduction; sweetness and food processing |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | CA2466877C Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 03/19/2009 | WO2009035092A1 Novel polypeptide and production method thereof |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | WO2009033212A1 The use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers |
| 03/19/2009 | US20090076247 High pressure refolding of monoclonal antibody aggregates |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075900 Therapeutic agent for motor neuron disease |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075335 Self-assembling protein hydrogel with bio-active protein |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074807 Moraxella (branhamella) catarrhalis antigens |
| 03/19/2009 | US20090074759 Using lymphocyte antigen binding profiles to diagnose and treat cancer; antitumor agents; administering an antibody or antigen binding fragment thereof that specifically binds to upregulated OX-2/CD200 |
| 03/19/2009 | US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof |
| 03/19/2009 | DE102007044673A1 Impfstoff zur Behandlung von Zöliakie und Verfahren zur Herstellung des Impfstoffes, Verwendung einer mit einem bakteriellen Toxin konjugierten Peptidsequenz zur Aktivierung des Immunsystems gegen Prolamine sowie Designerpeptid Vaccine for the treatment of celiac disease and method of producing the vaccine, Use of a conjugated with a bacterial toxin peptide sequence for activating the immune system against prolamines and Designer peptide |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2036584A1 Substrate for biological fluid treatment |
| 03/18/2009 | EP2035457A2 Vaccine carrier |
| 03/18/2009 | EP2000483A9 Vegf receptor fusion protein and use thereof |
| 03/18/2009 | EP1871785A4 Compositions and methods for fusion protein separation |
| 03/18/2009 | EP1463942B1 Methods for purifying protein |
| 03/18/2009 | CN101389791A Methods for generating and screening fusion protein libraries and uses thereof |
| 03/18/2009 | CN101389760A Peptides effective in the treatment of tumors and other peptides requiring the removal or destruction of cells |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386847A Recombinant bovine enterokinase, preparation method and use thereof |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/17/2009 | US7504483 α-β C4BP-type recombinant heteromultimeric proteins |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504224 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 03/17/2009 | CA2262546C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 03/17/2009 | CA2191895C Toxin assay |
| 03/13/2009 | CA2597878A1 Capsid protein and use therefore |
| 03/12/2009 | WO2009032954A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity |
| 03/12/2009 | WO2009031834A2 Hybridization method between leucine rich repeat family proteins |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069238 Activatable clostridial toxins |
| 03/12/2009 | DE102007042107A1 Pharmaceutical composition, e.g. for tumor therapy, comprises an iron-binding agent coupled to an active ingredient through a peptide linker comprising a protease recognition sequence |
| 03/12/2009 | CA2698357A1 Deletions in domain ii of pseudomonas exotoxin a that reduce non-specific toxicity |
| 03/12/2009 | CA2695960A1 Vegfr-1/nrp-1 targeting peptides |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033970A2 WNT-1 inducible genes |
| 03/11/2009 | EP2032607A1 Proteolytically cleavable fusion protein comprising a blood coagulation factor |
| 03/11/2009 | EP1699826B1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 03/11/2009 | EP1601698B1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384623A Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 03/11/2009 | CN101384617A Multimeric complexes of antigens and an adjuvant |